Pettiti Gianluca, an insider at Thermo Fisher Scientific Inc (TMO), executed a sale of 21,152 shares on November 9, 2025, at a price of $580.00 per share, resulting in a total transaction value of $12.27 million. Following this transaction, Gianluca retains 21,152 shares of the company.
Thermo Fisher Scientific operates in the Life Sciences Tools & Services industry, providing a broad array of innovative products and services to the scientific community. The company, headquartered in Waltham, Massachusetts, employs approximately 125,000 full-time staff. Its Life Sciences Solutions segment offers reagents, instruments, and consumables essential for biological and medical research, drug discovery, and disease diagnosis. The Analytical Instruments segment delivers instruments and related support, while the Specialty Diagnostics segment provides diagnostic test kits and reagents. Additionally, the Laboratory Products and Biopharma Services segment supplies comprehensive laboratory needs, including purification and filtration technologies.
Insider transactions, such as this sale, must be reported to the SEC, enhancing transparency regarding executive stock movements. While such transactions can reflect various personal motivations, they should not be the sole factor in investment decisions. Investors are encouraged to consider broader patterns of insider activity across multiple insiders and time frames.
As of November 13, 2025, Thermo Fisher Scientific has a market capitalization of $223.4 billion, a price-to-earnings ratio of 34.03, and an earnings per share figure of 17.30. The company is set to release its upcoming earnings on April 20, 2026, with an estimated EPS of $5.64 and revenue of $11.1 billion, followed by another report on July 20, 2026, expecting an EPS of $5.93 and revenue of $11.5 billion.